BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
BCRX earnings call for the period ending March 31, 2024.
Source: fool.com
Stay updated with breaking news from Stacy Ku. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BCRX earnings call for the period ending March 31, 2024.
Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.
BCRX earnings call for the period ending December 31, 2023.
Operator: Good morning, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals Third Quarter 2023 Corporate Update and Earnings Conference Call.
BCRX earnings call for the period ending September 30, 2023.